Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

BUY
$0.96 - $1.74 $41,559 - $75,326
43,291 Added 123.35%
78,387 $83,000
Q1 2019

May 14, 2019

BUY
$0.6 - $1.41 $21,057 - $49,485
35,096 New
35,096 $39,000
Q2 2018

Aug 08, 2018

SELL
$0.42 - $0.74 $37,590 - $66,230
-89,500 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$1.19 - $1.43 $106,505 - $127,985
89,500
89,500 $119,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $124M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.